Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-09

Clinical Trial Update: Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating PK interactions between dolutegravir and cenicriviroc, including cenicriviroc's effect on dolutegravir and the PK impact of a single-do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cenicriviroc (cenicriviroc)
  • Dolutegravir (dolutegravir)
  • Midazolam (Midazolam)

Snippet

Sponsor: Tobira Therapeutics, Inc. | Conditions: HIV-infection/AIDS | Phase 1 | Status: COMPLETED